NUVIA is pleased to announce it can now offer an HSE Approved Service to provide External Dosimetry to clients using the Mirion DMC 3000 Electronic Dosimeter.
The Health and Safety Executive (HSE) is Britain’s national regulator for workplace health and safety.
At present, NUVIA is the only UK organization approved by the HSE to provide this service using the DMC 3000 dosimeter. This is further complemented by its expertise and capability to provide approved Record Keeping, passive External Dosimetry and Internal Dosimetry Services.
The DMC 3000 dosimeter was developed by Mirion Technologies over two decades ago using experience and knowledge gained from real-world electronic dosimetry capabilities, and continually refined through customer feedback. It is currently the global reference in active dosimetry with more than 250,000 units deployed as of today.
The DMC 3000 dosimeter offers several key advantages:
- Reliability: designed for ruggedness and durability, with excellent electromagnetic interference immunity
- Best-in-class lead time from immediate availability for small/mid-size requests to optimized lead times for large systems
- Simple design, user-friendly ergonomics that are easy for start-up and normative usage
- Comprehensive ecosystem encompassing readers, software, telemetry, calibrator, connectivity and integrated solution, all contributing to heightened safety and efficiency
- Proven product reliability (>20 years) further reinforced by dedicated and recognized customer support
This External Dosimetry solution approved by HSE, provides all UK users with an alternative cost-effective option and therefore offers a real selection of choice by expanding their range of approved services.
For further information please contact Paula Quinn, Head of Talent Development & Communications, Tel: +44 (0)1925 858 262 Mob: (0)7714 916 273 [email protected].
Notes to Editors
NUVIA Group is an international nuclear engineering, project management, products and services contractor. It employs circa 3000 staff globally, generating annual sales of over £310M.
NUVIA is the nuclear division of Soletanche Freyssinet, a world leader in specialised civil and geotechnical engineering, and a wholly owned subsidiary of VINCI, the world’s largest integrated concessions and construction group. www.nuvia.com
Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionising radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,700 people and operates in 12 countries. Learn more at www.mirion.com